Drug profile · INN
desogestrel
KIMIDESS
desogestrel (KIMIDESS) is a progesterone receptor agonist. Associated with Teva Pharma GmbH. Route of administration: oral-21. Current US regulatory status: approved.
Drug details — desogestrel
- US status
- approved
- Class
- —
- Route
- ORAL-21
- Patents
- 0
- Programs
- 4
- Data quality
- 0.89
Quick answer
desogestrel (KIMIDESS) is a progesterone receptor agonist. Associated with Teva Pharma GmbH. Route of administration: oral-21. Current US regulatory status: approved.
Key facts
Mechanism of action
Progesterone receptor agonist
Primary target: Progesterone receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is desogestrel?
desogestrel (KIMIDESS) is a progesterone receptor agonist. Associated with Teva Pharma GmbH. Route of administration: oral-21. Current US regulatory status: approved.
What is the brand name for desogestrel?
KIMIDESS is a marketed brand name for desogestrel. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of desogestrel?
desogestrel has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.